Zusammenfassung
Unter den derzeit aktuellen Problemen auf dem Gebiet der Behandlung der Hypertonie möchte ich auf folgende Fragen näher eingehen:
-
Soll die sog. milde Hypertonie behandelt werden?
-
Welche Medikamente sind für die Behandlung der milden Hypertonie geeignet?
-
Besitzen β-Rezeptorenblocker eine „kardioprotektive“ Wirkung?
This is a preview of subscription content, log in via an institution.
Preview
Unable to display preview. Download preview PDF.
Literatur
Helgeland A (1980) Treatment of mild hypertension: a five year controlled drug trial. The Oslo study. Amer J Med 69: 725
Management Committee The Australian therapeutic trial in mild hypertension. Lancet 1980/1: 1261
Medical Research Council Working Party (1985) MRC trial of treatment of mild hypertension: principal results. Brit Med J 291: 97
Society of Actuaries (1972) Build and Blood Pressure Study. Society of Actuaries, Chicago (1959)
Dawber TR, Kannel WB (1972) Current status of coronary prevention. Prev Med 1: 499
Veterans Administration Cooperative Study Group on Antihypertensive Agents (1967) Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mmHg. J Amer med Ass 202: 1028
Veterans Administration Cooperative Study Group on Antihypertensive Agents (1970) Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mmHg. J Amer med Ass 213: 1143
Management Committee of the Australian Therapeutic Trial (1982) Untreated mild hypertension. Lancet 1: 185
Freis ED (1982) Should mild hypertension be treated? New Engl. J Med 307: 306
Smith WM (1977) Treatment of mild hypertension. Results of a ten-year intervention trial. US- Public Health Service Hospital Cooperative Study Group. Circ. Res., 40 (Suppl I), 98
Hypertension Detection and Follow-up Programm Cooperative Group (1979) Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. J Amer med Ass 242: 2562
Hypertension Detection and Follow-up Program Cooperative Group (1982) The effect of treat-ment on mortality in „mild“ hypertension. New Engl J Med 307: 976
Hypertension Detection and Follow-up Programm Cooperative Group (1982) Five-year findings of the hypertension detection and follow-up programm. III. Reduction in stroke incidence among persons with high blood pressure. J Amer med Ass 247: 633
Multiple Risk Factor Intervention Trial Research Group (1982) Multiple Risk Factor Interven-tion Trial. Risk factor changes and mortality results. J Amer med Ass 248: 1465
Guidelines for the treatment of mild hypertension (1983) memorandum from a WHO/ISH meeting. Lancet 1: 457
Wilkinson PR, Hesp R, Issler H, Raftery EB (1975) Total-body and serum potassium during prolonged thiazide therapy for essential hypertension. Lancet I: 759
Heimsoth V und Hartmann F (1965) Untersuchungen zur Störung des Harnsäurestoffwechsels nach Saluretica-Verabreichung. Dtsch Med Wschr 43: 1905
Distler A, Keim JH, Philipp Th, Walter U (1975) Blutdrucksenkende Wirkung von Spironolac-tone und von Butizid bei Patienten mit essentieller Hypertonie und niedrigem sowie mit norma-lem Plasmarenin. Therapiewoche 25: 3039
Jahnecke J (1973) Diabetogene Nebenwirkungen der Pharmakotherapie. Med Klin 68: 1046
Lewis PJ, Kohner EM, Petrie A, Dollery CT (1976) Deterioration of glucose tolerance in hyper-tensive patients on prolonged diuretic treatment. Lancet 1: 564
Murphy MB, Kohner E, Lewis PJ et al (1982) Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up. Lancet II: 1293
Amery A, Bulpitt C, Schaepdryver de A et al (1978) Glucose intolerance during diuretic therapy. Results of trial by the European Working Party on Hypertension in the Elderly. Lancet I: 681
Ames RP, Hill P (1976) Elevation of serum lipid levels during diuretic therapy of hypertension. Am J Med 61: 748
Grimm RH, Leon AS, Hunningh ake DB et al (1981) Effects of thiazide diuretics on plasma li-pids and lipoproteins in mildly hypertensive patients. Ann Int Med 94: 7
Schnaper H, Fitz A, Fröhlich E et al (1977) Chlorthalidone and serum cholesterol. Lancet II: 295
Glück Z, Baumgartner G, Weidmann P et al (1978) Increased ratio between serum ß- and α-li-poproteins during diuretic therapy: an adverse effect? Clin Sei Mol Med 55: 325s
Glück Z, Weidmann P, Mordasini R et al (1980) Increased serum low-density lipoprotein cholesterol in men treated short-term with the diuretic chlorthalidone. Metabolism 29: 240
Valimäki M, Harno K und Nikkilä EA (1983) Serum lipoproteins and indices of glucose tolerance during diuretic therapy: a comparison between hydrochlorothiazide and piretanide. J Cardiovasc Pharmacol 5: 525
Medical Research Council Working Party on Mild to Moderate Hypertension (1983) Ventricular extrasystoles during thiazide treatment: Substudy of MRC mild hypertension trial. Br Med J 287: 1249
Kaplan NM (1984) Our appropriate concern about hypokalemia. Am J Med 77: 1
Ames RP (1983) Negative effects of diuretic drugs on metabolic risk factors for coronary heart disease: possible alternative drug therapies. Am J Cardiol 51: 632
Berglund G, Sannerstedt R, Andersson O et al (1978) Coronary heart disease after treatment of hypertension. Lancet 1: 1
Materson BJ, Oster JR, Michael UF et al (1978) Dose response to chlorthalidone in patients with mild hypertension. Clin Pharmacol Ther 24: 192
Tweeddale MG, Ogilvie RI, Ruedy J (1977) Antihypertensive and biochemical effects of chlorthalidone. Clin Pharmacol Ther 22: 519
Lohmann FW (1981) Die Beeinflussung des Stoffwechsels durch Beta-Rezeptoren-Blocker. Klin Wochenschr 59: 49
Beta-Blocker Heart Attack Trial Study Group (1981) The Beta-Blocker Heart Attack Trial. J Am Med Assoc, 246: 2073
Norwegian Multicenter Study Group (1981) Timolol-induced reduction in mortality and rein- farction in patients surviving acute myocardial infarction. N Engl J Med 304: 801
Spivack C, Ockens S und Frishman H (1983) Calcium antagonists. Clinical use in the treatment of systemic hypertension. Drugs, 25: 154
The IPPPSH Collaborative Group (1985) Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blocker Oxprenolol: the International Prospective Primary Prevention Study in Hypertension (IPPPSH). J Hypertension 3: 379
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Distler, A. (1986). Arterielle Hypertonie - Aktuelle Probleme und Aufgaben. In: Lohmann, F.W. (eds) Hochdruck und Sport. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71181-7_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-71181-7_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-16531-6
Online ISBN: 978-3-642-71181-7
eBook Packages: Springer Book Archive